Andrew Gengos - Feb 24, 2025 Form 3 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Signature
/s/ David Strauss, as Attorney-in-Fact for Andrew Gengos
Stock symbol
TERN
Transactions as of
Feb 24, 2025
Transactions value $
$0
Form type
3
Date filed
2/25/2025, 06:10 PM
Previous filing
Sep 5, 2024

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney